Skip to content
Oncology Research Hub

Colorado

Cancer clinical trials in Colorado

314 cancer studies are recruiting participants at sites in 31 cities across Colorado as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Colorado by city

Cities with the most studies recruiting right now.

Every Colorado city with a recruiting study

By research area: Lung Cancer (88), Breast Cancer (85), Lymphoma (61), Prostate Cancer (36), Melanoma (24), Pancreatic Cancer (20).

Aurora (167), Denver (131), Lone Tree (39), Colorado Springs (38), Fort Collins (26), Lakewood (26), Grand Junction (25), Greeley (25), Loveland (25), Longmont (17), Highlands Ranch (16), Littleton (16), Pueblo (16), Boulder (14), Golden (14), Westminster (14), Englewood (12), Lafayette (12), Durango (11), Edwards (11), Thornton (9), Parker (8), Centennial (6), Wheat Ridge (6), Dillon (4), Vail (2), Brighton (1), Cheyenne Wells (1), Greenwood Village (1), Montrose (1), Steamboat Springs (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Colorado

Basic details from each study's public record (the 12 most recently updated of 314). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Aurora
    Registry record
    NCT06686394 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Colorado on ClinicalTrials.gov.

Lung cancer: recently updated in Colorado

  1. Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Aurora
    Registry record
    NCT05179408 · updated
  2. A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 to 99
    • All sexes
    Sponsor
    Erasca, Inc.
    Recruiting in
    Aurora
    Registry record
    NCT06983743 · updated
  3. A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Eikon Therapeutics
    Recruiting in
    Pueblo
    Registry record
    NCT07365319 · updated
  4. A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Aurora
    Registry record
    NCT07513376 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Colorado on ClinicalTrials.gov.

Prostate cancer: recently updated in Colorado

  1. Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Aurora
    Registry record
    NCT04038502 · updated
  2. High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Aurora
    Registry record
    NCT05011383 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Colorado on ClinicalTrials.gov.

Melanoma: recently updated in Colorado

  1. Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

    • Phase 3
    • Ages 75 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Aurora · Colorado Springs · Durango · and 4 more U.S. locations
    Registry record
    NCT07068074 · updated
  2. A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

    • Phase 1/2
    • From 6 months, up to 17 years
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Aurora
    Registry record
    NCT02332668 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Colorado on ClinicalTrials.gov.

Lymphoma: recently updated in Colorado

  1. Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Aurora
    Registry record
    NCT06806033 · updated
  2. A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Recruiting in
    Denver
    Registry record
    NCT07221500 · updated
  3. Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Recruiting in
    Aurora
    Registry record
    NCT07520006 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Colorado on ClinicalTrials.gov.

Ask about studies in Colorado

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call